GGrantIndex
Sort

130,381 grants matching hiv

WU-MDACC Inter-Institutional Molecular Imaging Center

$1,264,315
Samuel Achilefu · Washington University · P50 · FY2014 · CA

Mid Southern Primary Care Networks Node

$1,264,138
Li-Tzy T Wu · Duke University · UG1 · FY2017 · DA

Conduct Synthesis and Acquire Batches of Compounds for Subsequent Biological In Vitro and In Vivo Testing

$1,264,071
Mark Middleton · Starks Associates, Inc. · N01 · FY2024 · AI

Strategies to improve the HIV care continuum among key populations in India

$1,264,017
Gregory M Lucas · Johns Hopkins University · R01 · FY2021 · DA

NanoART Manufacture, Delivery and Pharmacokinetics for Optimizing Drug Adherence

$1,263,938
Howard Eliot Gendelman · University Of Nebraska Medical Center · P01 · FY2010 · DA

Investigating the development of AIDs and non-AIDS defining cancers in aged SIV-infected rhesus macaques.

$1,263,878
Scott W Wong · Oregon Health & Science University · R01 · FY2018 · CA

Immune correlates of protection

$1,263,878
Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI

Immune correlates of protection

$1,263,877
Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

Immune correlates of protection

$1,263,877
Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI

PS04-012, HIV PREVENTION PROJECTS

$1,263,843
Laurie Kops · Montana St Dept Of Hlth & Envrnmtl Scis · U62 · FY2007 · PS

Basic Research Support for the CCR

$1,263,819
Robert Wiltrout · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA

Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP

$1,263,633
Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

DUAL AFFINITY RE-TARGETING (DART) MOLECULES FOR HIV-1 SUPPRESSION

$1,263,565
Jeffrey Nordstrom · Macrogenics, Inc. · N01 · FY2018 · AI

Fc effector function in bNAbs

$1,263,378
Jeffrey Victor Ravetch · California Institute Of Technology · P01 · FY2016 · AI

Novel Ondansetron Formulation for Combination Treatment of Psychostimulant Abuse

$1,263,356
Tong H Lee · Duke University · RC2 · FY2010 · DA

HARLEM AIDS TREATMENT GROUP-'CPCRA'

$1,263,323
Columbia University Health Sciences · U01 · FY2004 · AI

HARLEM AIDS TREATMENT GROUP-'CPCRA'

$1,263,323
Columbia University Health Sciences · U01 · FY2003 · AI

PROVISION OF TECHNICAL ASSISTANCE TO STRENGTHEN HIV STRATEGIC INFORMATION ACTIVIT

$1,263,217
Dr. Christina P. Lindan · University Of California, San Francisco · U2G · FY2011 · PS

BODY COMPOSITION: METHODS, MODEL &CLINICAL APPLICATION

$1,262,934
St. Luke'S-Roosevelt Inst For Hlth Scis · P01 · FY2003 · DK

REPOSITORY FOR STORAGE, MONITORING, AND DISTRIBUTION OF NICHD BIOLOGICAL SPECIME

$1,262,707
Hannah Elson · Fisher Bioservices, Inc. · N01 · FY2011 · HD

Gut Homing Cells in SIV infection

$1,262,680
Aftab A. Ansari · Emory University · R01 · FY2013 · AI

Seek, Test, Treat: An Integrated Jail-Prison-Community Model for Illinois

$1,262,404
Lawrence J Ouellet · University Of Illinois At Chicago · R01 · FY2013 · DA

Preclinical Development of HIV-1 Vif Antagonists

$1,262,306
Mario Stevenson · University Of Miami School Of Medicine · P01 · FY2013 · MH

PS10-10133: INCREAS. ACC. TO QUAL. COMP. HIV PREVENTION SERVICES FOR MOST-AT-R

$1,262,200
Lawrence Gelmon · University Of Manitoba · U2G · FY2013 · PS

PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS

$1,261,993
Jennifer Brown · Utah State Department Of Health · U62 · FY2013 · PS